newsfilter
← Latest News
PR Newswire·

Number of shares and votes in BioArctic AB (publ) as of May 29, 2026

  • BioArctic AB issued 5,000 Class B shares in May 2026 via exercise of stock options from the 2019/2028 program resolved at the May 9, 2019 Annual General Meeting.
  • As of May 29, 2026, the company's total share capital consisted of 88,724,485 shares, comprising 74,324,489 listed Class B shares & 14,399,996 unlisted Class A shares.
  • Class A shares carry ten votes per share, while Class B shares carry one vote per share, resulting in a total of 218,324,449 votes for the company.
  • This disclosure was released on May 29, 2026, at 6:30pm CET in compliance with the EU Market Abuse Regulation.
  • BioArctic AB is a Swedish biopharma company focused on neurodegenerative diseases, known for co-developing Leqembi® with Eisai, & utilizes its proprietary BrainTransporter™ technology.
  • BioArctic's Class B shares (BIOA B) are listed on Nasdaq Stockholm Large Cap.